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Abstract Three different fractional (methanol, ethyl
acetate and hexane) extracts from yuzu (Citrus junos Sieb
ex Tanaka), hallabong [(C. unshiu Marcov 9 C. sinensis
Osbeck) 9 C. reticulata Blanco] and orange (C. sinensis)
were evaluated for their antioxidant activity and anti-
platelet effects. 2,2-Diphenyl-1-Picrylhydrazyl (DPPH),
cupric reducing antioxidant capacity (CUPRAC) and fer-
ric-reducing antioxidant power (FRAP) methods were used
for the antioxidant activity tests. Total flavonoids and total
phenolics were also evaluated spectrophotometrically. The
ethyl acetate fraction contained the highest total flavonoid
and total phenolic content and exhibited the highest
antioxidant activities (185.2 ± 14.5 and 208.7 ± 17.5 mg/
g dry extract for FRAP and CUPRAC values, respectively).
The total phenolic and total flavonoid content ranged
from 58.2 ± 1.4 to 102.4 ± 8.6 and 19.6 ± 0.5 to
64.3 ± 0.8 mg/g dry extract, respectively. The results of
DPPH assay showed that ethyl acetate fractions had the
least IC50 values (0.12 ± 0.002, 0.04 ± 0.0006, in mg/mL
for orange and hallabong samples, respectively) followed
by the hexane fraction (0.19 ± 0.007 mg/mL) of the
orange sample. For all fractions, the antioxidant activity
and contents of total phenolics and total flavonoids corre-
lated well with each other. In vitro investigation of the
antiplatelet effect showed that ethyl acetate fraction has the
highest inhibition (84.3 ± 5.8 to 96.1 ± 1.8 %). Hexane
and MeOH fractions of hallabong and orange samples
inhibited platelet aggregations by less than or equal to
41 %.
Keywords FRAP  DPPH  Platelet aggregation  Total
phenolics  Citrus fruits
Introduction
Because of the unhealthy lifestyle and aged population,
mortality associated with cancer and cardiovascular dis-
eases has increased (Fuentes et al. 2013a). Reactive oxygen
species (ROS) are known to play a dual role, being either
harmful or beneficial to living systems. ROS have benefi-
cial effect in defense against infectious agents, in the
function of a number of cellular signaling systems and in
the induction of a mitogenic response at low concentra-
tions. At high concentrations, ROS can be important
mediators of damage to cell structures, including lipids and
membranes, proteins and nucleic acids (Valko et al. 2006).
ROS play an important role in degenerative or pathological
processes such as cancer (Valko et al. 2006), coronary
heart disease (Watt et al. 2012), neurodegenerative disor-
ders (Roy et al. 2008), atherosclerosis (Patel et al. 2000)
and inflammation (Kielland et al. 2009). The development
of cardiovascular diseases such as acute myocardial
infarction, cerebrovascular disease and peripheral arterial
thrombosis is related to the interaction process of
atherosclerotic lesions and thrombus formation. This
interaction is basically established with the participation of
platelets (Fuentes et al. 2013b). Platelets adhere to
endothelial cells and contribute to the recruitment of
leukocytes involved in the local vascular inflammation and
thrombosis formation (Jackson et al. 2009). Several syn-
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the aggregation of platelets (Cruz et al. 1998; Yu et al.
2011). However, it has been reported that synthetic drugs
are accompanied by several adverse side effects. Low-dose
aspirin increases the risk of major bleeding and intestinal
ulceration (Schror 1997). The term ‘aspirin resistance’ has
been used to describe the failure of aspirin to inhibit pla-
telet activity. Between 8 and 45 % of patients who suffered
an ischemic stroke or cardiovascular disease are aspirin
resistant (Ohmori et al. 2006). Therefore, the development
of safe, alternative therapeutic agents with antiplatelet
activity is crucial. Reports show that plant-derived foods
like spinach, which is rich in nitrates, apple rich in flavo-
noids and tomato in lycopene exhibit antiplatelet activity
(Bondonno et al. 2012; Fuentes et al. 2013a). Plants are
believed to be valuable sources of antioxidants. Epidemi-
ological studies suggest that consumption of fruits and
vegetables is associated with significantly lower risk of
coronary artery disease and stroke (Hu 2003).
The health benefits of citrus fruits are largely attributed
to the presence of the relatively high concentrations of
antioxidant compounds, such as ascorbic acid and phenolic
compounds, mainly flavonoids (Gonza´lez-Molina et al.
2010; Kawaii et al. 1999). Various studies showed that
extracts from citrus peels exhibited antiplatelet activities
besides their antioxidant activity (Sagdic et al. 2011; Yu
et al. 2005). Although it is believed that citrus fruits have
several beneficial health effects, it is not clear whether the
individual bioactive components or the group of com-
pounds having relatively similar characteristics plays the
most significant role in antioxidant and antiplatelet activi-
ties. Over the past few decades, many studies have been
conducted on the quantification of phenolic compounds,
organic acids, carotenoids, limonoids and antioxidant
capacity of different citrus fruit genotypes originated
across the world (Abeysinghe et al. 2007; Goulas and
Manganaris 2012; Kawaii et al. 1999; Ramful et al. 2010;
Vasco et al. 2008). The quantity and types of bioactive
compounds and their biological activity markedly differ
between fruit varieties, parts, cultivars within the same
species or within the same cultivar grown in diverse cli-
matic conditions and cultivation practice (Cano et al. 2008;
Goulas and Manganaris 2012; Jayaprakasha and Patil 2007;
Vasco et al. 2008; Yoo et al. 2004). This might be attrib-
uted to the difference in genetics, climate, soil type and
other conditions. Studies showed that yuzu, hallabong and
orange are good sources of pectin (Lim et al. 2012; Yeoh
et al. 2008), terpenoids (limonin, nomilin, limonene, sabi-
nene, c terpinene) (Choi 2003; Kim et al. 2013), flavo-
noid glycosides (hesperidin, naringin) (Hoshino et al.
2014), polymethoxyflavones, hydroxylated poly-
methoxyflavones, polymethoxyflavanones and poly-
methoxychalcones (tangeretin, nobiletin, phloretin,
sinensetin) (Hoshino et al. 2014; Li et al. 2006). Groups of
bioactive compounds with closely related physicochemical
characteristics have a greater chance of dissolving in a
similar solvent. Studying the nutraceutical properties, e.g.,
antioxidant and antiplatelet activity of citrus fruit, in dif-
ferent solvent fractions can give information related to
which compounds researchers have to focus for further
study. The results of such studies, therefore, can be useful
as a starting point of view for the applications of citrus
fruits or their constituents in functional food preparations
and pharmaceutical industries such as for the development
of alternative antiplatelet therapies from specific fractions
of citrus extract.
Consequently, this study aimed at the evaluation of the
antioxidant and collagen-induced antiplatelet activities in
different fractional extracts (methanol, ethyl acetate and
hexane) from three citrus varieties, which are commonly
consumed in Korea.
Experiments
Plant material and sample preparation
Three different fruits of citrus (orange (C. sinensis), hal-
labong [(C. unshiu Marcov 9 C. sinensis Osbeck) 9 C.
reticulata Blanco] and yuzu (Citrus junos Sieb ex Tanaka))
grown in Korea were collected. Samples which were
commercially mature without any sign of damage were
used for the study. Orange and hallabong were purchased
directly from the market, Seoul, Korea. Yuzu was obtained
from a farm in Jeju Province, South Korea. Samples were
stored at -80 C till extraction. Composite samples were
prepared by mixing equal amounts of slices from ten
healthy fruits, free of visible blemishes or disease.
Approximately, 50 g of properly mixed and chopped
sample was extracted according to the procedure described
in ‘‘Extraction procedure and preparation of dried frac-
tions’’ of this article. The extracted samples were stored at
-20 C until analysis.
Chemicals and reagents
In this study, methanol, n-hexane, ethyl acetate and water
were used. Both n-hexane and methanol were of greater
than 99 % purity. Water was purified using a Millipore
Milli-Q Reference system. Hydrochloric acid, phenol and
sulfuric acid, methanol and n-hexane were supplied by
DAEJUNG (Gyonggi do, South Korea). Ammonium acet-
ate, ferric trichloride hexahydrate and 2,4,6-tripyridyl-s-
triazine (TPTZ) were from JUNSEI (Tokyo, Japan).
Sodium acetate and 2,2-diphenyl-1-picrylhydrazyl (DPPH)
were from Fluka (Buchs, Switzerland). Acetic acid, the
Folin–Ciocalteu reagent and sodium carbonate were from
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Sigma-Aldrich (Buchs, Switzerland). Dimethyl sulfoxide
(DMSO), acetylsalicylic acid (aspirin) (ASA), standards of
gallic acid, neocuproine, 6-hydroxy-2,5,7,8-tetram-
ethylchroman-2-carboxylic acid (Trolox), quercetin and
ascorbic acid were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Collagen was purchased from Chrono-
Log Co. (Harvertown, PA, USA). All reagents used for
analysis were of analytical or high-purity grade.
Extraction procedure and preparation of dried
fractions
The extraction was done with 1 % HCl in 80 % MeOH.
In brief, fresh fruit samples (50 g) were homogenized for
3 min with 50 mL (1 % HCl in 80 % MeOH). Another
450 mL of 1 % HCl in 80 % methanol was added to the
homogenate and extracted by a magnetic stirrer for 6 h at
room temperature and centrifuged at 10,000 rpm for
15 min at 4 C. The residue was re-extracted by adding
100 mL of 1 % HCl in 80 % methanol two times. All
supernatants were combined, filtered and the solvent was
removed using a rotary evaporation. The crude extract
was fractionated sequentially with n-hexane (HE), ethyl
acetate (EA) and methanol (MeOH). Solutions of each
partitioned fractions were dried under a speed vacuum
concentrator (Biotron Inc., Gyeonggi-Do, South Korea).
The yields of each fraction were: 4.02 g methanol, 1.59 g
ethyl acetate, 0.15 g hexane for yuzu; 4.13 g methanol,
1.62 g ethyl acetate, 0.16 g hexane for hallabong; and
4.06 g methanol, 1.62 g ethyl acetate, 0.18 g hexane for
orange.
Determination of total phenolic and flavonoid
contents
The total phenolic (TP) content was determined by the
Folin–Ciocalteu method with some modification (Singleton
et al. 1999). Briefly, 0.1 mL extract sample was added to
15 mL tube containing 2.3 mL of deionized water. 0.4 mL
of Folin–Ciocalteu reagent was added to the mixture. The
mixture was kept at room temperature for 7 min and then
1.2 mL of 20 % sodium carbonate was added. The reaction
was allowed to continue for 60 min. Absorbance was
measured at 765 nm against blank using a Shimadzu UV-
1700 spectrophotometer calibrated by gallic acid and
results were reported in milligrams of gallic acid equiva-
lents (GAE) per gram of dried extract.
The total flavonoid concentrations of each fraction were
determined by the colorimetric aluminum chloride method
(Chang et al. 2002; Naqinezhad et al. 2012). 0.5 mL
solution of appropriately diluted sample solutions was
separately mixed with 1.5 mL methanol, 0.1 mL of 10 %
aluminum chloride, 0.1 mL of 1 M potassium acetate and
2.8 mL of deionized water and left at room temperature for
30 min. The absorbance of the reaction mixture was
measured at 415 nm using a Shimadzu UV-1700 spec-
trophotometer. The results were reported in milligram of
quercetin equivalents (QE) per gram of dried extract.
DPPH radical-scavenging activity
The protocol of DPPH radical-scavenging activity test was
adapted from Brand-Williams et al. (1995) with some
changes. Solutions of each fraction in a volume of 100,
200, 300, 400 and 500 lL were added to 2.5 mL of
0.1 mM DPPH in methanol and made up to 3 mL with
methanol. The DPPH solution mixed with pure methanol
instead of the extract was used as a control. The mixture
was shaken vigorously and left to stand for 80 min in the
dark. Preliminary experiments have shown that such a long
interval is required for the reaction to be completed. The
absorbance was recorded at 517 nm. Pure methanol was
used as a reference. Vitamin C, TROLOX and quercetin
were used as a standard control. IC50 values denote the
concentration of the sample, which is required to scavenge
50 % of DPPH radicals.
Ferric-reducing power determination
The ferric-reducing antioxidant potential of each fraction
was estimated by the method of Benzie and Strain (1996).
Briefly, the FRAP reagent was prepared from 25 mL of
300 mM acetate buffer (pH 3.6), 2.5 mL of 10 mM TPTZ
solution in 40 mM HCl and 2.5 mL of 20 mM FeCl3.6H2O
solution. The reagent was prepared immediately before use
as required. The assay procedure consisted in mixing 3000
lL of FRAP reagent, 300 lL of water and 100 lL of the
test sample or standard TROLOX solution. The reaction
mixture was kept at 37 C for 90 min. The results were
reported as milligrams of TROLOX equivalents (TE) per
gram of dried extract.
Copper ion-reducing power determination
The protocol of the CUPRAC test was adapted from Apak
et al. (2004) with a little modification. Briefly, to a test tube
was added 1 mL each of 10 mM CH3COONH4. To this
mixture, 100 lL of the extracted sample (standard) solution
and 1 mL of water were added, so as to make a final vol-
ume of 4.1 mL. The tubes were stoppered and after 30 min
the absorbance at 450 nm was recorded against a reagent
blank. The assay was calibrated with standard solutions of
TROLOX to express results in milligrams of TE per gram
of dried extract.
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Preparation of platelets
Sprague–Dawley rats (Daehan laboratory Animal Center,
Korea) weighing 200–250 g were slightly anesthetized
with diethyl ether. Blood was collected from the abdom-
inal aorta using a syringe into a tube containing 3.8 %
sodium citrate (1:9, v/v), and then centrifuged at
1300 rpm for 10 min at room temperature. The super-
natant (platelet-rich plasma; PRP) obtained was used in
the aggregation study.
Determination of platelet aggregation
Studies of platelet aggregation were performed using a
turbidimetric method (Cazenave et al. 2004). In brief,
platelet counts in PRP were counted using hemocy-
tometer after 10 lL PRP was diluted by adding 500 lL
Tyrode solution (pH 7.4, NaCl 134 mM, KCl 3 mM,
MgCl2 2 mM, NaH2PO4 0.3 mM, NaHCO3 11.9 mM,
distilled water 500 mL) containing bovine serum albu-
min (35 mg/mL) to obtain a platelet density low enough
for counting and then, adjusted to 2 9 108 cells/mL
with the Tyrode solution. PRP was stimulated with an
aggregating agent (collagen) at a final concentration of
2 lg/mL. Platelet aggregations were recorded 5 min
after platelet stimulation. Aggregations were measured
by a Lumi-aggregometer (Chrono-Log, Co., Havertown,
PA, USA) connected to the computer and expressed as
percent changes in light transmission, taking the value
of a blank sample (buffer without platelets) to be
100 %. PRP was preincubated with different concentra-
tions of the samples for 5 min in the cuvette of an
aggregometer before being stimulated with the aggre-
gating agent described above.
Statistical analysis
All analyses were carried out in triplicate, and data were
reported as a mean ± SD. The data were analyzed by the
SPSS 17.0 software using one-way ANOVA and
homogenous subsets were determined to separate the
mean values of the different treatments. Means which
were statistically significantly different (p\ 0.05) were
marked with different alphabetical letters. The IC50 values
were calculated from linear regression analysis. Anti-
platelet results were expressed as percent inhibition of
control (as 100 %). A Pearson correlation test was used to
evaluate the relationship between the antioxidant activi-
ties, total phenol content, total flavonoid content and
antiplatelet activity of the fractions. The statistical sig-
nificance level for correlation analysis was set up at
p\ 0.05 and p\ 0.01.
Results
Total phenolic and flavonoid content
The total phenolic content ranged from 8.8 ± 0.06 to
102.4 ± 8.6 mgGAE/g of dried extract (Table 1). The
results are expressed as gallic acid equivalents by reference
to a standard curve (y = 3.4837x ? 0.0053, r2 = 0.993).
The total phenolic (TP) content of each solvent fraction
showed a similar trend in all three samples tested. The
trend decreased in the following order: ethyl acetate frac-
tion[ hexane fraction[methanol fraction. As it can be
seen, the ethyl acetate concentrates most phenolic com-
pounds of intermediate polarity. The total flavonoid (TF)
contents, which are reported as QE/g of dried extract by a
reference standard curve (y = 0.0064x - 0.0953.
r2 = 0.9998), showed a similar trend as the TP content.
DPPH radical-scavenging activity
The free radical-scavenging activity was expressed as an
IC50 value (Table 2). The ethyl acetate fraction showed the
least in all samples followed by the hexane fraction. The
values were 3.7 ± 0.1, 4.1 ± 0.2 and 5.7 ± 0.2 for yuzu;
1.2 ± 0.02, 4.3 ± 0.1 and 10.4 ± 0.4 for hallabong;
0.4 ± 0.006, 1.9 ± 0.07 and 10.1 ± 0.3 for orange in mg/
10 mL for EA, hexane and methanol fractions, respec-
tively. The IC50 values for TROLOX, quercetin, and
ascorbic acid standards were 0.11, 0.12 and 0.07 mg/
10 mL, respectively.
FRAP and CUPRAC assay
The antioxidant activity by the FRAP method indicated
that the ethyl acetate fraction exhibited the highest
antioxidant activity (approximately, three times in yuzu,
six times in orange and nine times in hallabong higher than
the methanol fraction which was found to be the least
active). A similar trend was also observed for the CUPRAC
assay. The antioxidant capacities using a CUPRAC and
FRAP assays given as milligrams TROLOX equivalent
(TE) per gram of dried extract are presented in Table 1. It
is apparent from the table that the hierarchy is ethyl
acetate[ hexane[methanol fraction in all samples
tested.
Antiplatelet activity
In vitro platelet aggregation and inhibition study induced
by the agonist collagen, with added fractional extracts of
citrus fruits was conducted and the results are presented in
Fig. 1. All the fractions inhibited platelet aggregation to a
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different extent. The inhibition of platelet aggregation was
observed in the following order: ethyl acetate[
methanol[ hexane. The trend is in a similar fashion for all
the three citrus species tested. Dose response experiments
for fractions of yuzu extract were found to inhibit collagen-
induced platelet aggregations in a dose-dependent manner
(Fig. 2). Yuzu fractions at 1 mg/mL blocked platelet
aggregations by 96.1 ± 1.8, 79.9 ± 2.1 and 77 ± 6.7 %
for the EA, MeOH and hexane fractions, respectively. The
EA fractions of all the fruit samples were found to inhibit
platelet aggregation by more than 80 %. However, the
hexane and MeOH fractions of hallabong and orange
samples inhibited platelet aggregations by less than or
equal to 41 %. Inter-species comparison showed that 1 mg/
mL of each fraction inhibited the aggregation of platelets in
the order yuzu[ hallabong[ orange for the EA and
hexane fractions. However, the order of inhibition for the
methanol fraction is yuzu[ orange[ hallabong. Overall,
it was observed that the yuzu extract was relatively more
potent in inhibiting platelet aggregation than either hal-
labong or orange. Aspirin was tested for comparison.
0.3 mg/mL aspirin blocked collagen-induced platelet
aggregation by 95.7 %, which is almost equal to 1 mg/mL
of ethyl acetate fraction of yuzu.
Correlations
The correlation coefficients of total phenolic content with
total flavonoid, FRAP, CUPRAC and % inhibition of
platelet aggregation were found to be 0.963, 0.906, 0.991
and 0.654, respectively. The DPPH radical-scavenging
activity of the fractions as measured by IC50 also showed
good correlations (negative) with the total phenol, total
flavonoid, FRAP and CUPRAC and poorly correlated with
percent inhibition of platelet aggregation (Table 3). The
highest correlation of inhibition of platelet aggregation was
with total phenol and the least with FRAP (0.380).
Discussion
As presented in the previous sections, the ethyl acetate
fraction contained a significant value of phenolic content
and antioxidant activity. It also inhibited the aggregation of
platelets relatively better than other fractions. Fractions
with a high phenolic content showed a higher antioxidant
potential and percent inhibition of platelet aggregation. The
Table 1 Total phenol, total flavonoid and antioxidant activities (measured by FRAP and CUPRAC methods) of different solvent fractions of
yuzu, hallabong and orange extracts





FRAP (mgTE/g dry extract) CUPRAC
(mgTE/g dry extract)
Yuzu Methanol 14.7 ± 0.5e 3.0 ± 0.05g 21.5 ± 0.1e 27.4 ± 2.3e
Ethyl acetate 51.2 ± 1.6c 19.6 ± 0.5c 67.4 ± 0.3c 93.0 ± 1.0b
Hexane 26.5 ± 3.1d 18.3 ± 1.3d 39.8 ± 0.7d 46.0 ± 3.2d
Hallabong Methanol 8.8 ± 0.06e 2.3 ± 0.04gh 19.4 ± 0.04e 16.1 ± 0.2e
Ethyl acetate 102.4 ± 8.6a 64.3 ± 0.8a 185.2 ± 14.5a 208.7 ± 17.5a
Hexane 26.2 ± 4.1d 8.6 ± 4.7e 114.3 ± 6.9b 57.7 ± 6.0c
Orange Methanol 10.3 ± 0.3e 1.9 ± 0.004 h 19.3 ± 0.1e 16.8 ± 1.3e
Ethyl acetate 58.2 ± 1.4b 22.9 ± 0.8b 119.9 ± 3.8b 96.3 ± 3.1b
Hexane 10.6 ± 0.6e 5.8 ± 0.2f 20.5 ± 0.7e 25.9 ± 2.3e
Data expressed as means ± standard deviations of three independent extractions (n = 3). Different letters indicate statistically significant
differences between the means (p\ 0.05)
Table 2 DPPH scavenging capacity of different solvent fractions of
yuzu, hallabong and orange expressed as IC50 values
Fruit Solvent IC50 (mg dry
ext/10 mL)
Yuzu Methanol 5.7 ± 0.171b
Ethyl acetate 3.7 ± 0.121d
Hexane 4.1 ± 0.240c
Hallabong Methanol 10.4 ± 0.369a
Ethyl acetate 1.2 ± 0.024f
Hexane 4.3 ± 0.138c
Orange Methanol 10.1 ± 0.256a
Ethyl acetate 0.4 ± 0.006g
Hexane 1.9 ± 0.071e
Trolox 0.11 ± 0.008h
Quercetin 0.12 ± 0.01h
Ascorbic acid 0.07 ± 0.003h
Data expressed as means ± standard deviations of three independent
extractions (n = 3). Different letters indicate statistically significant
differences between the means (p\ 0.05)
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concentration of total flavonoids, which is well correlated
with total phenolic content, explains just a small fraction of
the later value. Considering that the above-mentioned
characteristics are expressed in different equivalent units,
their direct comparison is not quite correct. The total
phenolic content and total flavonoid content of the different
solvent fractions of the studied fruit sample ranged from
8.8 ± 0.06 to 102.4 ± 8.6 mgGAE/g of dried extract and
1.9 ± 0.004 to 64.3 ± 0.8 mgQE/g of dried extract,
respectively. The combined values of the total flavonoid
contents of yuzu (40.9 mgQE/g) and orange (30.6 mgQE/g)
were close to that reported for a sample of C. tanakan
Hayata (39.6 ± 0.92), C. reticulate x C. sinensis
(39.8 ± 1.02), C. limon (L.) Bur (32.7 ± 1.06), C. sinensis
(L) Osbeck (35.5 ± 1.04) and C. microcarpa
(41.0 ± 1.37) in milligrams of rutin equivalents/gram from
Taiwan (Wang et al. 2008). However, the value for hal-
labong fruit (75.2 mgQE/g) was quite large. The combined
values of total phenolic content of the studied fruit samples
ranged from 79.1 to 137.4 mgGAE/g. This variation range
is higher than that (29.38–51.14 mgGAE/g) of methanolic
extracts of C. reticulata Blanco from china (Zhang et al.
2014), but quite in agreement with that (104.2–172.1
mgGAE/g) of C. reticulata Blanco fruits from Iran (Gha-
semi et al. 2009).
Three methods were used in this study to measure the
antioxidant activity of fractions of citrus extracts: the
DPPH, FRAP and CUPRAC assays. These methods eval-
uate somewhat different aspects of antioxidant properties.
The DPPH assay measures the so-called radical-scavenging
activity (RSA) that is the ability of extract constituents to
scavenge reactive species and, in such a way, to stop the
initiation or propagation of oxidizing chain reactions. The
free DPPH radical serves as a substrate of radical-trapping
reactions in this method. Three different standards which
are well known for their antioxidant activity, TROLOX,
quercetin and ascorbic acid, were used as suggested by
Parejo et al. (2000). Ascorbic acid exhibited the lowest
IC50 value. IC50 values denote the concentration of sample
required to scavenge 50 % of DPPH free radicals. Ascorbic
acid was found to be a approximately six times more
powerful DPPH radical scavenger than the most active EA
acetate fraction of orange extract, 0.04 mg/mL of which
scavenged 50 % of DPPH free radicals. 0.011 and
0.012 mg/mL of TROLOX and quercetin standards were
required to scavenge 50 % of DPPH free radicals which
was 3.6 times and 3.3 times less than the EA acetate
fraction of orange extract, respectively. Ethyl acetate
fraction of the hallabong and hexane fraction of orange
scavenged DPPH free radical moderately (IC50\ 200 lg/
mL). Other fractions showed no relevant scavenging
capacity (IC50[ 200 lg/mL). The ethyl acetate fraction
showed higher levels of total phenolic and flavonoid con-
tents than other fractions in all the samples tested. The high
phenol and flavonoid content in ethyl acetate fractions may
also contribute to its potent DPPH radical activity. Phenol
and flavonoid can reduce the stable DPPH radical either by
the process of hydrogen or electron donation where the
color changes from blue to yellow. The blue color DPPH
radical has a strong absorption at 517 nm, which reduce as
the color changes. The degree of reduction in absorbance is
an indication of the antioxidant activity of the sample.
In the CUPRAC and FRAP assay, the presence of the
electron donor in the sample would result in the reduction
of Cu2? to Cu? and Fe3? to Fe2?, respectively. The for-
mation of reduced ions, in both cases, increases the
absorbance of the sample which indicates the reductive
ability of the sample. Plant-derived antioxidants are
chemically diverse and complex in nature, making it dif-
ficult to separate, quantify and identify the individual
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Fig. 1 In vitro inhibitory effect of different fractions of yuzu
(1.0 mg/mL), hallabong (1.0 mg/mL), orange (1.0 mg/mL) and
aspirin (0.3 mg/mL) on platelet aggregation induced by collagen


























Fig. 2 Dose-dependent in vitro inhibitory effect of different fractions
of yuzu fruit on platelet aggregation induced by collagen (2 lg/mL)
(n C 3 mean ± SD *p\ 0.05 vs vehicle)
109 Page 6 of 10 3 Biotech (2016) 6:109
123
antioxidants exhibit varying reducing potency in different
solvents. In this study, the ethyl acetate fractions showed
significantly higher FRAP and CUPRAC values (3–13
times higher), while the methanol part exhibited the least.
Among the three tested citrus samples, hallabong showed
the highest FRAP and CUPRAC values (Table 2).
The results of collagen-induced platelet aggregation
inhibition experiment are reported in Figs. 1 and 2. Col-
lagen induces platelet activation through a tyrosine kinase-
based signaling pathway (Yu et al. 2011). New therapeutic
design strategies related to cardiovascular research are
becoming more centered on platelets (Palomo et al. 2008).
Various reports show that naturally consumed compounds
(dietary components, nucleosides, fats, flavonoids) in our
regular diet inhibit the activation of platelets (Fuentes et al.
2012). Citrus fruits are sources of numerous bioactive
compounds such as flavonoids, carotenoids, ascorbic acid,
essential oils and others (Espina et al. 2011; Kefford and
Chandler 1970; Yoo et al. 2009). Chlorogenic acid, caffeic
acid, ferulic acid and p-coumaric acid have been reported
to inhibit ADP-, collagen-, TRAP-6- and AA- induced
platelet aggregations (Fuentes et al. 2013a, b). Yuzu con-
tains various phenolic compounds such as chlorogenic
acid, ferulic acid, rutin, rutin hydrate, narirutin, naringin,
apigen-7-glucoside, hesperidin, quercetin and tangeretin
(Tao et al. 2014; Yang et al. 2013). Swatsitang et al. (2000)
identified various phenolic compounds including ferulic
acid, p-coumaric acid, caffeic acid, hesperetin, hesperidin,
naringenin, naringin, rutin, phloridzin, myricetin, luteolin,
kaempferol and quercetin from Citrus sinensis. Naringin
and hesperidin which are found to be the major flavanones
in yuzu (Yoo et al. 2009) were found to exhibit limited
platelet aggregation inhibitory effect (Yu et al. 2011).
However, the same study results showed that the
methanolic extract of yuzu fruit inhibits platelet aggrega-
tion significantly where the mechanism responsible may
involve the inhibition of TXA2 formation. Phloretin is
another flavonoid component of yuzu fruit (Suetsugu et al.
2013) which is reported to reduce platelet aggregation
stimulated by adenosine diphosphate (ADP) in human
platelets (Stangl et al. 2005). Hesperetin, the aglycone form
of hesperidin, inhibits platelet aggregation induced by
collagen and arachidonic acid in a dose-dependent manner,
mediated by the inhibition of PLC c2 phosphorylation
and cyclooxygenase-1 activity (Jin et al. 2007). Nobiletin, a
known citrus polymethoxy flavone which possesses anti-
cancer, antiviral and anti-inflammatory activities, was
found to inhibit platelet function significantly in vitro in
washed platelets, PRP and whole blood (Vaiyapuri et al.
2015). Catechin also inhibits cyclooxygenase (COX)
activities and platelet aggregation (Huss et al. 2002). Rutin
is a flavonoid inhibiting platelet aggregation in human
platelets stimulated by the COL agonist. The mechanism
may involve the following pathways: rutin inhibits the
activation of phospholipase C, followed by inhibition of
protein kinase C activity and TXA2 formation, thereby
leading to inhibition of the phosphorylation of platelet
protein of M(r) 47000 (P47), a marker of protein kinase C
activation and intracellular Ca2? mobilization, and finally
resulting in the inhibition of platelet aggregation (Sheu
et al. 2004). Flavonoids inhibit platelet aggregation either
by inhibiting the formation of endogenous mediators
derived from phospholipid peroxidation, by blocking
enzymatic free radical production, or by reducing platelet
sensitivity to agonists by preventing lipid peroxidation
(Neiva et al. 1999; Salvemini and Botting 1993). However,
dietary phenolics appear in the circulatory system not as
the parent compounds, but predominantly as glucuronide,
sulfate and methylated metabolites, and their presence in
plasma after dietary intake is at very low concentrations
(Crozier et al. 2010; Del Rio et al. 2013). Hence, their
possible clinical effect on platelets in concentrations
achievable in plasma is rather limited to few of them and
might be caused by their metabolites (Crozier et al. 2010;
Table 3 Correlation coefficients of total phenol, total flavonoid, FRAP, CUPRAC, DPPH and inhibition of platelet aggregation of extracts of



















Total phenol (mgGAE/g dry extract) 1.000
Total flavonoid (mgQE/g dry extract) 0.963b 1.000
FRAP (mgTE/g dry extract) 0.906b 0.855b 1.000
CUPRAC (mgTE/g dry extract) 0.991b 0.976b 0.915b 1.000
DPPH (IC50, mg dry extract/10 mL) -0.646
a -0.600a -0.636a -0.632a 1.000
Inhibition of platelet aggregation
(% of vehicle)
0.654a 0.569 0.380 0.583a -0.436 1.000
a Correlation is significant at the 0.05 level (1-tailed)
b Correlation is significant at the 0.01 level (1-tailed)
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Karlı´cˇkova´ et al. 2016). In vitro studies of antiplatelet
activity of plant extracts alone are inconclusive due to the
insufficiencies in the study design, providing very less
information about the interaction of the compounds with
human physiological and pathological processes. Hence,
better performed in vivo intervention and in vitro mecha-
nistic studies are needed to fully understand how these
molecules interact with human physiological and patho-
logical processes (Del Rio et al. 2013). Our search results
show that antiplatelet activity of extracts of hallabong has
not been reported so far. In this paper, different fractions of
the three citrus varieties yuzu, hallabong and orange, were
studied. Ethyl acetate fractions exhibited potential inhibi-
tion of platelet aggregation in all the varieties. Despite the
fact that the methanol fraction contained lower contents of
phenolics, flavonoids and less antioxidant activities, it was
found to inhibit aggregation of platelets a little better than
the hexane fraction. This is probably due to the difference
in the potential of individual compounds taking part in the
inhibition of platelet aggregation. The antiplatelet activities
of a yuzu sample in hexane and methanol fraction were
also quite appreciable and comparable to the ethyl acetate
fraction.
Conclusions
The fractions showed very good antioxidant activities in
the studied samples. EA fractions showed the strongest
antioxidant activity and higher phenolic and flavonoid
content followed by the hexane fraction. The EA fractions
were also found to have the strongest antiplatelet activity
compared with the methanol and hexane fraction. The
results indicate that antiplatelet and antioxidant activities
of citrus fruits are not only due to a particular group of
compounds, but also due to a synergic effect of compounds
with different characteristics. The fractions of fruit samples
contain complex compounds. To obtain the pure compound
with high antiplatelet activity requires a further study. The
differences in the potential of individual compounds taking
part in the inhibition of platelet aggregation and the con-
centrations of the compounds extracted from each fraction
also affect the inhibition potential of the fractions. The
antiplatelet activity seems to be attributed to the combined
effects of the bioactive components of the studied citrus
fruits. These results can be useful as starting point of view
for further applications in food and pharmaceutical prepa-
rations after performing clinical in vivo researches.
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